Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Corteva, Inc. Director's Dealing 2019

Jun 10, 2019

30037_dirs_2019-06-10_b23edd29-c92b-454d-b8bd-c5ec2b3a72dc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Corteva, Inc. (CTVA)
CIK: 0001755672
Period of Report: 2019-06-01

Reporting Person: GAJARIA RAJAN (See Remarks)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 47065.7714 Direct
Common Stock 32 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Options $27.27 2024-02-14 Common Stock (7129) Direct
Non-Qualified Stock Options $28.86 2025-02-13 Common Stock (5760) Direct
Non-Qualified Stock Options $26.86 2026-02-12 Common Stock (18317) Direct
Non-Qualified Stock Options $35.72 2027-02-10 Common Stock (13897) Direct
Non-Qualified Stock Options $41.94 2028-02-15 Common Stock (5393) Direct

Footnotes

F1: On June 1, 2019, the Reporting Person received a dividend of one (1) share of Corteva, Inc. common stock for every three (3) shares of DowDuPont Inc. held by the Reporting Person, and the Reporting Person's equity awards denominated in DowDuPont common stock were adjusted, in part, into equity awards denominated in Corteva common stock, all as described in Corteva's Registration Statement on Form 10 filed with the Securities and Exchange Commission on May 6, 2019. This amount includes restricted stock units and related dividend equivalent units.

F2: On June 1, 2019, the Reporting Person received a dividend of one (1) share of Corteva, Inc. common stock for every three (3) shares of DowDuPont Inc. held by the Reporting Person, all as described in Corteva's Registration Statement on Form 10 filed with the Securities and Exchange Commission on May 6, 2019.

F3: In connection with the separation, certain outstanding DowDuPont stock options were converted into awards of options to purchase shares of the Issuer's common stock. The number of shares and exercise prices of each option award were adjusted in a manner intended to preserve the economic/intrinsic value of the original DowDuPont stock option.

F4: This option is fully vested and exercisable.

F5: 9,264 options are vested and exercisable. The remaining options will vest on February 10, 2020.

F6: 1,797 options are vested and exercisable. The remaining options will vest in two equal installments on February 15, 2020 and February 15, 2021.